Although coverage restrictions remain in place, the trendiness of weight loss drugs may be creating a growing cost concern ...

Cigna's Evernorth business caps GLP-1 drug copays at $200 or ... has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss medications at $200 per month, in a ...

Omada Health went public on the Nasdaq Friday, marking the second major digital health company to do so after a post-pandemic ...

Some Blue Cross and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs, then ...

Specialty benefit vendors have made big promises about lower costs and healthier workers. Employers are now demanding ...

Diabetes care startup Omada Health went public Friday 14 years after its founding. Here's what its major investors' stakes ...

The team at Omada Health took a victory lap Friday after the company's successful Nasdaq debut, according to company ...

Fifteen Connecticut companies made the 2025 Fortune 500 list of the largest U.S. corporations, which was announced Monday-- a sign of stability in the state's corporate sector. Bloomfield- ...

Shares in Omada Health (NASDAQ:OMDA) rose 21% in their Nasdaq debut on Friday, closing at US$23 after pricing at US$19 in the ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.